Restricted accessResearch articleFirst published online 2016-8
Appearance of Focal Liver Lesions Using Contrast-Enhanced Magnetic Resonance Imaging Using Gadofosveset Trisodium,an Intravascular (Blood-Pool) Contrast Agent: A Pictorial Essay
JangH.J.KimT.K.WilsonS.R.Imaging of malignant liver masses: characterization and detectionUltrasound Q2006; 22:19–29.
2.
MilotL.HaiderM.FosterL.Gaodofosveset trisodium in the investigation of focal liver lesions in noncirrhotic liver: early experienceJ Magn Reson Imaging2012; 36:738–742.
3.
BannasP.MotosugiU.HernandoD.Combined gadoxetic acid and gadofosveset enhanced liver MRI: a feasibility and parameter optimization studyMagn Reson Med2016; 75:318–328.
4.
SabachA.S.BrunoM.KimD.Gadofoseveset trisodium: abdominal and peripheral vascular applicationsAJR Am J Roentgenol2013; 200:1378–1386.
5.
SilvaA.C.EvansJ.M.McCulloughA.E.MR imaging of hypervascular liver masses: a review of current techniquesRadiographics2009; 29:385–402.
6.
ChungY.E.KimM.J.ParkY.N.Varying appearances of cholangiocarcinoma: radiologic-pathologic correlationRadiographics2009; 29:683–700.
7.
JiaG.O'DellC.HeverhagenJ.T.Colorectal liver metastases: contrast agent diffusion coefficient for quantifictation of contrast enhancement heterogeneity at MR imagingRadiology2008; 248:901–909.
8.
ElsayesK.M.NarraV.R.YinY.Enhancement pattern approach with contrast-enhanced 3D gradient-echo MR imagingRadiographics2005; 25:1299–1320.
9.
MorkH.IgneeA.SchuesslerG.Analysis of neuroendocrine tumour metastases in the liver using contrast enhanced ultrasonographyScand J Gastroenterol2007; 42:652–662.
